Resonance Health Ltd (ASX: RHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Resonance Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $27.26 million
P/E Ratio 100.00
Dividend Yield 0.00%
Shares Outstanding 446.89 million
Earnings per share -0.002
Dividend per share N/A
Year To Date Return 1.67%
Earnings Yield 1.00%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Resonance Health Ltd (ASX: RHT)
    Latest News

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Here's why the Resonance Health (ASX:RHT) share price is rocketing 36% today

    The company's shares are on fire. Here are the details

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development
    Share Market News

    Here's why the Resonance Health (ASX:RHT) share price rocketed

    The Resonance Health share price rocketed more than 16% today before closing 5% higher. We take a look at what's…

    Read more »

    pause button on digital screen representing asx trading pause
    Share Market News

    Resonance Health (ASX:RHT) announces its share price is in trading halt

    The Resonance Health share price was edging higher today before the company announced that it would be entering a trading…

    Read more »

    rising ASX Telstra share price represented by man jumping in the air for joy looking at mobile phone
    Share Market News

    The Resonance Health (ASX:RHT) share price has rocketed up 9% today. Here's why.

    The Resonance Health (ASX: RHT) share price is soaring up today after the company announced a deal using its artificial…

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development
    Share Market News

    Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today

    The Resonance Health Limited (ASX: RHT) share price is shooting 39% higher today after the company announced an important FDA…

    Read more »

    Share Gainers

    Why Afterpay, Creso Pharma, Healius, & Resonance Health shares are storming higher

    Afterpay Ltd (ASX:APT) and Healius Ltd (ASX:HLS) shares are two of four storming notably higher on Wednesday. Here's why...

    Read more »

    a woman
    Share Market News

    Here's why these 3 ASX shares are trading higher today

    Here are 3 ASX shares performing strongly today, providing some indication as to what's pushing the S&P/ASX 200 Index (INDEXASX:XJO)…

    Read more »

    a woman
    Share Market News

    Why the Resonance Health share price is rocketing 20% higher

    The Resonance Health Limited (ASX: RHT) share price has rocketed 20% after the company released an announcement this morning.

    Read more »

    a woman
    ⏸️ Investing

    The WORST investing mistake I've made recently

    A wise person learns from the mistakes of others...

    Read more »

    RHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Resonance Health Ltd

    Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

    RHT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    14 Jun 2024 $0.06 $0.00 0.00% 50,299 $0.06 $0.06 $0.06
    12 Jun 2024 $0.06 $0.00 0.00% 163,923 $0.06 $0.06 $0.06
    11 Jun 2024 $0.06 $0.00 0.00% 431,978 $0.06 $0.06 $0.06
    07 Jun 2024 $0.06 $0.00 0.00% 35,649 $0.06 $0.06 $0.06
    06 Jun 2024 $0.06 $0.00 0.00% 220,980 $0.06 $0.06 $0.06
    05 Jun 2024 $0.07 $0.00 0.00% 385,643 $0.06 $0.07 $0.06
    04 Jun 2024 $0.06 $0.00 0.00% 94,505 $0.06 $0.06 $0.06
    03 Jun 2024 $0.06 $0.00 0.00% 20,867 $0.06 $0.06 $0.06
    31 May 2024 $0.06 $0.00 0.00% 20,999 $0.06 $0.06 $0.06
    30 May 2024 $0.06 $0.00 0.00% 525,000 $0.06 $0.06 $0.06
    29 May 2024 $0.06 $0.00 0.00% 194,527 $0.07 $0.07 $0.06
    28 May 2024 $0.06 $0.00 0.00% 166,018 $0.07 $0.07 $0.06
    22 May 2024 $0.07 $0.00 0.00% 100,000 $0.07 $0.07 $0.07
    21 May 2024 $0.07 $0.00 0.00% 13,963 $0.07 $0.07 $0.07
    20 May 2024 $0.07 $0.00 0.00% 137,740 $0.07 $0.07 $0.07
    17 May 2024 $0.07 $0.00 0.00% 75,000 $0.07 $0.07 $0.07
    16 May 2024 $0.07 $0.00 0.00% 261,012 $0.07 $0.07 $0.07

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    08 Apr 2024 Simon Panton Buy 500,000 $32,500
    On-market trade.
    20 Mar 2024 Simon Panton Buy 500,000 $23,000
    On-market trade.
    20 Mar 2024 Simon Panton Transfer 73,300,000 $4,617,900
    Off-market transfer. Assuming off market transfer of shres
    20 Mar 2024 Simon Panton Transfer 73,300,000 $4,617,900
    Off-market transfer. Assuming off market transfer of shares
    20 Oct 2023 Mitchell Wells Buy 610,000 $36,600
    Conversion of securities. As per announcement on 20-10-2023
    20 Oct 2023 Mitchell Wells Exercise 610,000 $36,600
    Conversion of securities. 1,220,000 unquoted Performance Rights, As per announcement on 20-10-2023
    27 Sep 2023 Travis Baroni Buy 610,000 $44,622
    On-market trade. average price
    05 Sep 2023 Aaron Brinkworth Buy 300,000 $19,676
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Martin Peter Blake Non-Executive DirectorNon-Executive Chairman Oct 2007
    Dr Blake is a Radiologist and Nuclear Physician and brings significant technical and industry experience to Resonance Health. Dr Blake received FAANMS as a post nominal in recognition of his Nuclear Medicine Specialist training undertaken in 1994 & 1995. He has been a Partner of Perth Radiological Clinic since 1997 and is currently on the Board of that Company. He is a member of Risk committee.
    Mr Mitchell MacDonald Wells Company SecretaryNon Executive Director Jun 2023
    Mr Wells is an experienced senior executive and a qualified lawyer with commercial and legal experience in Australia, the United States of America and the United Kingdom. He has served as a Director and worked as a senior executive of public and private companies including ASX and US Nasdaq listed public companies. He recently served as Chair of two large non-profit organisations and he has previously served as the company secretary of two ASX listed public companies and as the corporate secretary of a US Nasdaq listed public company. He currently serves as a director of several private companies.
    Mr Simon Panton Non-Executive Director Oct 2009
    Mr Panton has been a strong supporter of the Company and the FerriScan technology over a number of years and is a major shareholder of Resonance Health. Mr Panton brings skills in business and marketing having run his own successful business. He is a member of Risk committee.
    Dr Travis Baroni Non-Executive Director Nov 2016
    Mr Baroni has broad experience across industrial research, commercialisation of technology, asset valuations and investment banking services. He has managed innovation development and technology strategy in a large company setting as well as being an active investor in early stage investments. He has worked in investment banking, providing advisory services to equity capital market transactions, corporate research and valuations to clients. He is the chair of Risk committee.
    Mr Aaron Brinkworth Non-Executive Director Mar 2023
    Mr Brinkworth had a 22-year career with US headquartered, Nasdaq listed, Gilead Sciences, Inc. (Nasdaq: GILD). Mr Brinkworth held several commercial, licensing, and patient access roles, including that of Executive Director - Gilead Sciences Global Patient Solutions. He has served on the Board of Directors of the Royal Surf Lifesaving Society of Western Australia since 2020.
    Mr Andrew Duncan Harrison Chief Executive Officer Jul 2023
    -
    Andrew Duncan Harrison Chief Executive Officer
    -
    Ms Liesl Ellies Joint Company secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Southam Investments 2003 Pty Ltd <Warwickshire Investment A/C> 73,800,000 16.00%
    HSBC Custody Nominees (Australia) Limited 48,501,078 10.52%
    Acuity Capital Investment Management Pty Ltd <Acuity Capital Holdings A/C> 20,000,000 4.34%
    Ms Alison Virginia Wesley <Wesley Family A/C> 9,940,000 2.16%
    Mr Paul John Van Dyk 9,116,947 1.98%
    Mr William Murray Thompson 6,658,660 1.44%
    Ms Jade Louise Thompson 6,512,759 1.41%
    Mr Bruce Alan Stevenson 6,400,000 1.39%
    Mr Helmut Rocker 5,256,471 1.14%
    Mr Paul Andrew Fitzmaurice & Mrs Tania Marie Fitzmaurice <Fitzmaurice Family S/F A/C> 5,250,000 1.14%
    Marcolongo Nominees Pty Ltd <Marcolongo Family A/C> 5,186,200 1.12%
    Dr Russell Kay Hancock 4,610,000 1.00%
    Mr Harish Garg 4,501,245 0.98%
    Mr Thomas Psarakis 4,434,777 0.96%
    Dr Martin Peter Blake 3,798,590 0.82%
    Morgan Stanley Australia Securities (Nominee) Pty Limited (No 1 Account) 3,589,171 0.78%
    Fullerton Private Capital Pty Limited 3,500,000 0.76%
    The University Of Western Australia 3,478,750 0.75%
    Neweconomy Com Au Nominees Pty Limited (900 Account) 3,202,660 0.69%
    Citicorp Nominees Pty Ltd 2,574,632 0.56%

    Profile

    since

    Note